Sentence examples for microarray hybridization assay from inspiring English sources

A microarray hybridization assay for identification of chlamydiae was developed using the ArrayTube™ platform.

To study the global distribution of origins of DNA replication in human chromosomes we have followed a strategy which utilizes a DNA microarray hybridization assay to measure the enrichment of short nascent strand DNA obtained from asynchronous proliferating cells.

The identification of differentially expressed genes or patterns of gene expression using a microarray hybridization assay provides a logical approach to developing potential biomarkers of toxicity.

This strategy provides new design options for microarray hybridization assays to detect RNA abundance, RNA splice variants, or sequence polymorphisms.

Overall, qRT-PCR analysis confirmed the variations in expression levels noticed in microarray hybridization assays resulting in an inflammatory signature in DCs treated with the highest dose of probiotic.

The respective RNA preparations were used in two DNA microarray hybridization assays by applying label swapping.

The microarray hybridization assays were carried out in two experimental repeats of the RNA samples obtained from A549/DDP cells (Cy5-labeled) and A549 cells (Cy3-labeled).

In microarray hybridization assays single-stranded nucleic acid targets – contained in a complex mixture of diffierent target sequences in solution – freely diffuse over the surface-tethered probes until they are captured by a complementary probe.

The need for validation comes from the unavoidable fact that in microarray based hybridization assays there is always some degree of cross-hybridization to be accounted for, which may vary depending on the hybridization conditions as well as specific probe properties, such as sequence, length and GC content.

In our microarray-based hybridization assays the binding affinity of mispaired duplexes is dominated by the influence of defect position.

The first stage of the genetic study will be to perform highthroughput cytogenetic screening using a microarray-based Comparative Genomic Hybridization assay specially designed to detect microdeletions and duplications (microdels/dups), including sub-telomeric abnormalities, too small to be identified by standard karyotyping.